KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewell Personal Care (EPC) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Edgewell Personal Care (EPC) over the last 17 years, with Q3 2025 value amounting to $27.6 million.

  • Edgewell Personal Care's Capital Expenditures rose 656.37% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.0 million, marking a year-over-year increase of 3628.32%. This contributed to the annual value of $77.0 million for FY2025, which is 3628.32% up from last year.
  • Edgewell Personal Care's Capital Expenditures amounted to $27.6 million in Q3 2025, which was up 656.37% from $15.5 million recorded in Q2 2025.
  • In the past 5 years, Edgewell Personal Care's Capital Expenditures ranged from a high of $27.6 million in Q3 2025 and a low of $6.5 million during Q4 2023
  • For the 5-year period, Edgewell Personal Care's Capital Expenditures averaged around $15.1 million, with its median value being $12.6 million (2024).
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 5192.31% in 2023, then surged by 15846.15% in 2024.
  • Edgewell Personal Care's Capital Expenditures (Quarter) stood at $9.4 million in 2021, then rose by 20.21% to $11.3 million in 2022, then plummeted by 42.48% to $6.5 million in 2023, then soared by 158.46% to $16.8 million in 2024, then soared by 64.29% to $27.6 million in 2025.
  • Its Capital Expenditures stands at $27.6 million for Q3 2025, versus $15.5 million for Q2 2025 and $17.1 million for Q1 2025.